ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation
Author(s): Hasegawa W, Pond GR, Rifkind JT, Messner HA, Lau A, Daly AS, Kiss TL, Kotchetkova N, Galal A, Lipton JH
Source: BONE MARROW TRANSPLANTATION    Volume: 35    Issue: 1    Pages: 51-55    Published: JAN 2005  
Times Cited: 14     References: 15     
Abstract: The purpose of this study was to evaluate the estimated incidence of secondary malignancies post-allogeneic bone marrow transplantation (BMT) in a cohort of adult patients previously reported now with an additional 8.5 years of follow-up. A cohort of 557 patients older than age 16 years underwent allogeneic BMT between June 1970 and November 1993. Histologic reports confirmed the diagnosis of a secondary malignancy. Multivariate Cox proportional hazards method was utilized to investigate predictors for the development of secondary malignancies. In all, 31 patients in this cohort developed a secondary malignancy a median of 6.79 years after their transplant. The estimated cumulative incidence rate of secondary malignancy was 4.2% at 10 years post transplant. When compared to the general population, the estimated observed/expected ratio of new cancer diagnoses was 5.13. On multivariate analysis, older age at the time of transplant was the only significant predictor for development of secondary cancer (P=0.01). The most common malignancies observed were nonmelanomatous skin cancers and squamous cell cancers of the buccal cavity. The risk of developing a secondary malignancy after allogeneic BMT is significant, particularly in older patients. Long-term survivors of transplant require regular monitoring for early signs of cancer, particularly of the skin and oral cavity.
Document Type: Article
Language: English
Reprint Address: Lipton, JH (reprint author), Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Allogene Bone Marrow Transplant Serv, 610 Univ Ave, Toronto, ON M5G 2M9 Canada
Addresses:
1. Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Allogene Bone Marrow Transplant Serv, Toronto, ON M5G 2M9 Canada
2. Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Dept Biostat, Toronto, ON M5G 2M9 Canada
Publisher: NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
Subject Category: Biophysics; Oncology; Hematology; Immunology; Transplantation
IDS Number: 880ET
ISSN: 0268-3369
DOI: 10.1038/sj.bmt.1704706
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo